WILLIAM R LARUE
CIK 1265784 · SVP, CFO, Treas, Asst Sec · last filed 2024-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
41
Lifetime Open-Market Net
-$487.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 26,174 | $0.53 | $13.8K | $0 | 9 | 2024-06-24 |
| Tracon Pharmaceuticals, Inc. (TCON) Delisted | Director | 7,763 | $0.03 | $250 | $24.9K | 6 | 2023-04-21 |
| Histogen Inc. (CNAT) Delisted | Director | — | — | — | $0 | 3 | 2019-07-01 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | SVP, CFO, Treas, Asst Sec | 24,500 | — | — | -$512.1K | 16 | 2014-02-12 |
Recent Filings · Page 3 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-05 | — | Sell (S) | −2,500 | -$6.7K | |
| 2017-02-07 | Histogen Inc. (CNAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-02 | — | Grant (A) | +7,500 | $0 | |
| 2015-07-24 | — | Grant (A) | — | $0 | |
| 2014-03-21 | — | Mixed | −16,000 | -$224.0K | |
| 2014-02-12 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-18 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Mixed | — | -$50.3K | EDGAR |
| 2013-11-18 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Mixed | — | -$147.6K | EDGAR |
| 2013-07-17 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Mixed | — | -$36.5K | EDGAR |
| 2013-06-27 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Mixed | — | -$36.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.